Trial
NCT05139914
Assessment of Dapagliflozin on Vascular Health in Patients With Type 2 Diabetes
Phase IVTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Boston University
Collaborators
American Heart Association
Condition
Diabetes Mellitus, Type 2
Intervention
Dapagliflozin
Why stopped
The study was halted early because of the inability to enroll participants.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-02-11